-
Study aim
-
Determination of rotator cuff tear repair extent through ultrasound-guided injection of platelet-rich plasma
-
Design
-
A non-randomized clinical trial, without a control group, and without blinding, phase 1, will be conducted on 40 patients.
-
Settings and conduct
-
This study will utilize patients with partial tendon tears who meet the study's inclusion criteria. Patients will be selected from the specialized Sports Medicine Clinic and, after obtaining informed consent, will participate in the study. Platelet-rich plasma will be prepared and injected under ultrasound guidance. Clinical and radiographic measurements of patients will be performed before, immediately after, and two months after injection, along with relevant sonographic evaluations. After data collection and analysis, the results will be reported in the final thesis.
-
Participants/Inclusion and exclusion criteria
-
Age range: 18 to 80 years old; Primary tear; Traumatic or degenerative tear with less than 50% thickness
-
Intervention groups
-
A clinical trial study is planned in patients with rotator cuff tears in the city of Mashhad in the year 1403. Patients will be selected from the specialized Sports Medicine Clinic and, after obtaining informed consent, will participate in the study. Inclusion criteria for the study include ages between 18 and 80 years old, tendon tear less than 50%, and willingness to participate in the study. Exclusion criteria from the study include secondary rotator cuff tear due to fracture or dislocation. Patients will receive three injections of platelet-rich plasma under ultrasound guidance, and ultrasound imaging will be performed before injection, after injection, and two months later. Data will be collected, and the study results will be reported in the final thesis.
-
Main outcome variables
-
Percentage of tear; mediolateral tear length; pain level; shoulder range of motion; tear repair